Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

West Pharmaceutical Services, Inc. Common Stock (NY: WST )

331.40 +4.39 (+1.34%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
A Look Into West Pharmaceutical Servs Inc's Price Over Earnings
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $9,100 Today
Via Benzinga
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Via Benzinga
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028
EQNX::TICKER_START (NASDAQ:STSS),(NYSE:STVN),(NYSE:WST),(NYSE:BDX),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
These Are The 12 Stocks Driving The S&P 500 Higher In 2023
The index is up 12.5% so far in 2023, but an equal-weight ETF is up just 1%. 
Via Investor's Business Daily
Topics ETFs Stocks
Exposures US Equities
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Via Benzinga
3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years
Are these highly successful stocks still good buys today? 
Via The Motley Fool
Here's How Much $1000 Invested In West Pharmaceutical Servs 10 Years Ago Would Be Worth Today
Via Benzinga
The 3 Best Retirement Stocks to Buy Now: September 2023
Here are the best retirement stocks to buy. Each has a unique growth catalyst on the horizon and impressive financial results. 
Via InvestorPlace
Topics Retirement
Exposures Pension
WEST PHARMACEUTICAL SERVICES (NYSE:WST) can be considered a quality stock. Here's why.
Why the quality investor may take a look at WEST PHARMACEUTICAL SERVICES (NYSE:WST). 
Via Chartmill
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 10 Years
Via Benzinga
What 4 Analyst Ratings Have To Say About West Pharmaceutical Servs
Via Benzinga
Why NYSE:WST qualifies as a quality stock.
WEST PHARMACEUTICAL SERVICES (NYSE:WST) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
A Look Into West Pharmaceutical Servs Inc's Price Over Earnings
Via Benzinga
$100 Invested In West Pharmaceutical Servs 15 Years Ago Would Be Worth This Much Today
Via Benzinga
West Pharmaceutical Services Inc. (NYSE: WST) Sets New 52-Week High in Tuesday Session
Via Investor Brand Network
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
Via Benzinga
Worried About Market Froth? Buy These 3 Dividend Stocks
If you are concerned about the massive rallies in tech leading to sharp corrections, then taking profits or adding other positions could be a prudent move. One place to look for solace when the broader... 
Via Talk Markets
West Pharmaceutical Servs: Dividend Insights
Via Benzinga
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
$1000 Invested In West Pharmaceutical Servs 20 Years Ago Would Be Worth This Much Today
Via Benzinga
P/E Ratio Insights for West Pharmaceutical Servs
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $62,000 Today
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
Via Benzinga
10 Safest Dividend Aristocrats For 2023
A company cannot pay rising dividends for 25+ years without having a strong and durable competitive advantage. But some Dividend Aristocrats are better than others, based on the sustainability of their... 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Via Benzinga
NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday
Raymond James boosted the price target for Jabil Inc. (NYSE: JBL) from $100 to $120. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares rose 5% to close at $104.64 on... 
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.